Geratherm Medical AG: Geratherm Medical AG announces preliminary figures for financial year 2021
Geratherm Medical AG / Key word(s): Preliminary Results
Publication of insider information in accordance with Article 17 MAR,
Geratherm Medical AG announces preliminary figures for financial year 2021:
- Revenues EUR 23.9 million (2020: EUR 27.5 Million)
- EBITDA 2,304 kEUR (2020: 4,347 kEUR)
- EBITDA-Margin 9.6% (2020: 15.8%)
- Operating profit (EBIT) 590 kEUR (without depreciation of medical heating blankets for clinical surgery: 1,517 kEUR) (2020: 3,097 kEUR)
- result from ordinary operations 308 kEUR (2020: 2,719 kEUR)
- Earnings per share 2 cents (2020: 41 cents)
- Equity ratio 54.0% (2020: 55.4%)
- Cash and securities EUR 6.5 million (2020: EUR 10.3 million)
- Proposed dividend: 12 cents per share (2020: 40 cents per share)
- Ongoing good international demand for Geratherm medical products
Geratal, April 7, 2022: Geratherm Medical AG (ISIN: DE0005495626) had a stable sales trend in 2021 after the record year 2020. The result was burdened by the one-off expenses of the discontinuation of the medical heating blankets for clinical surgery and further certification expenses.
Geratherm Respiratory and apoplex medical had a good development in 2021. Sales split of the divisions Healthcare Diagnostic EUR 13.9 million, -24.3%; Respiratory EUR 5.6 million, +15.6%; Medical warming systems EUR 2.0 million, -18.5%; Cardio/Stroke 2.5 million EUR, +34.0%.
The detailed Annual Report 2021 will be published on April 26, 2022.
Geratherm Medical AG
Short company profil:
07-Apr-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Geratherm Medical AG|
|Phone:||+49 (0)36205 98-0|
|Fax:||+49 (0)36205 98-1 15|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1323249|
|End of Announcement||DGAP News Service|